Iteos Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $35,000 | $0 | $-11,303 | $0 |
Gross Profit | 34,691 | -303 | -11,536 | -224 |
EBITDA | -13,857 | -46,929 | -37,016 | -42,008 |
EBIT | -14,166 | -47,232 | -37,249 | -42,232 |
Net Income | -7,128 | -38,216 | -30,551 | -32,241 |
Net Change In Cash | 35,000 | 0 | -11,303 | 0 |
Free Cash Flow | -34,369 | -33,345 | -15,161 | -34,641 |
Cash | 251,098 | 146,648 | 251,177 | 204,134 |
Basic Shares | 39,699 | 35,843 | 35,838 | 35,783 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $12,595 | $267,630 | $344,775 | $0 |
Gross Profit | 11,697 | 266,817 | 344,160 | -535 |
EBITDA | -143,989 | 130,390 | 255,685 | -38,772 |
EBIT | -144,887 | 129,577 | 255,070 | -39,307 |
Net Income | -112,642 | 96,652 | 214,521 | -38,033 |
Net Change In Cash | 12,595 | 267,630 | 344,775 | 0 |
Cost of Revenue | -555,271 | 512,381 | 316,464 | |
Free Cash Flow | -106,722 | -112,131 | 511,959 | -25,532 |
Cash | 251,177 | 284,803 | 848,537 | 336,326 |
Basic Shares | 35,763 | 37,766 | 37,774 | 35,044 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.18 |
2024-03-31 | -$1.07 |
2023-12-31 | -$0.85 |
2023-09-30 | -$0.90 |
